Sign in

Christopher Harned

Director at QUAD
Board

About Christopher B. Harned

Christopher B. Harned (age 62) has served on Quad/Graphics’ Board since 2005 and is Chair of the Finance Committee. He is Co‑Founder and Managing Partner of Windhover Capital; prior roles include Partner and Head of the New York office at Arbor Investments (2016–2020), Managing Director and Head of Consumer Products–Americas at Nomura, Managing Director in M&A at Robert W. Baird (from January 2012), Partner/MD and Head of Consumer Products at The Cypress Group, and 16 years at Lehman Brothers. He holds a BA from Williams College (1985) .

Past Roles

OrganizationRoleTenureCommittees/Impact
Windhover CapitalCo‑Founder & Managing PartnerCurrentPrivate equity leadership focused on food/consumer sectors
Arbor InvestmentsPartner; Head of NY OfficeSep 2016 – Oct 2020Led NY office; consumer investing
Nomura Securities InternationalMD; Head of Consumer Products – AmericasPrior to 2016Consumer M&A leadership
Robert W. Baird & Co.MD, Investment Banking M&AFrom Jan 2012Consumer M&A
The Cypress Group LLCPartner, MD; Head of Consumer Products GroupFrom 2001Private equity leadership
Lehman BrothersMD; Global Head Consumer Products M&A16 yearsGlobal consumer M&A leadership

External Roles

OrganizationRoleStatusNotes
Titan Frozen FruitDirectorCurrentPrivate company board
Lakeview Farms, Inc.DirectorCurrentPrivate company board
Southeastern Meats, Inc.DirectorCurrentPrivate company board
Freshpet, Inc.DirectorFormerServed on Audit and Compensation Committees (public company)
Other former boardsDirectorFormerRed Collar Pet Foods; bswift; Danka Business Systems PLC; The Meow Mix Company; Stone Canyon Entertainment; Brand Connections LLC; Philadelphia Media Network

Board Governance

  • Independence: Not independent due to family relationships (brother‑in‑law of CEO J. Joel Quadracci and Director/QuadMed CEO Dr. Kathryn Quadracci Flores; spouse Elizabeth Quadracci Harned is a trustee of the Quad Voting Trust) .
  • Committee assignments: Chair, Finance Committee (oversight of capital structure, financing, cash flow modeling, interest rate sensitivity; 3 meetings in 2024) . Not listed as a member of Audit or Compensation Committees .
  • Attendance: The Board held 7 meetings in 2024; each director attended at least 75% of Board and assigned committee meetings; all directors attended the 2024 Annual Meeting .
  • Controlled company: Quad is NYSE “controlled company” under the Quad Voting Trust; exempt from certain NYSE independence requirements; no lead independent director .
  • Executive sessions: Board and independent directors met in executive session regularly in 2024 .

Fixed Compensation (Non‑Employee Director Pay)

ComponentQUAD 2024 PolicyHarned 2024 Amount
Annual retainer$235,000 (50% cash; 50% deferred stock units) Cash: $134,500; Equity (DSUs): $125,000; Other: $10,000; Total: $269,500
Committee chair feesAudit: $25,000; Compensation: $20,000; Finance: $17,000 Finance Chair fee included in cash figure above
Director comp capMax total value per non‑employee director per year: $675,000 Within cap
Deferral planMay elect to defer cash fees or take DSUs in lieu of cash Program available

Performance Compensation

  • Directors receive equity via deferred stock units (DSUs) as the equity portion of the annual retainer; no performance metrics apply to non‑employee director grants .
  • None of the non‑employee directors had stock options outstanding as of 12/31/2024 .
Equity ElementDesign2024 Grant Basis
Deferred stock units (DSUs)Equity portion of retainer; value‑based grantNumber of DSUs determined using 20‑day VWAP prior to grant

Other Directorships & Interlocks

  • Family/Trust interlocks: Harned is brother‑in‑law to the CEO and to Director/QuadMed CEO Dr. Flores; his spouse, Elizabeth Quadracci Harned, is a trustee of the Quad Voting Trust which controls >50% voting power .
  • External public boards: None disclosed currently; former public board service at Freshpet, Inc. (Audit and Compensation Committees) .

Expertise & Qualifications

  • Core expertise: Consumer/food sector private equity; M&A advisory; capital markets; board service on consumer businesses .
  • Education: BA, Williams College (1985) .
  • Governance relevance: Finance Committee chair role aligns with capital structure and financing expertise .

Equity Ownership

Holder/TypeClass A Shares% of Class AClass B Shares% of Class BNotes
Christopher B. Harned (beneficial)572,2961.54%236,9001.79%Includes 64,530 Class A DSUs convertible within 60 days; 50,205 Class A and 2,888 Class B held by a trust where Harned is trustee; spouse holds 265,311 Class A and 234,012 Class B
Quad Voting Trust (context)7,534<1%12,279,38092.59%Trustees: J. Joel Quadracci; Dr. Kathryn Q. Flores; Elizabeth Quadracci Harned

Insider Trades and Ownership Alignment

Date (Filing)FormSecurity/TypeQuantity/DetailNote
2025‑05‑23Form 4Class A via DSUs22,004Footnote indicates holdings include 22,004 DSUs granted under QUAD 2020 Omnibus Incentive Plan (annual director grant)
  • Policies: Quad prohibits hedging by directors and requires pre‑approval for any pledging; directors have stock ownership guidelines equal to at least 4x the cash portion of the annual retainer .
  • Clawback: Awards under the 2020 Plan (including director equity) are subject to company recoupment/clawback and stock ownership policies and any applicable legal requirements .

Governance Assessment

Positives

  • Deep consumer/M&A and capital markets expertise aligned to Finance Committee remit; chairs Finance Committee (capital structure, financing, cash flow modeling) .
  • Material equity ownership and annual DSU grants help align incentives with shareholders; ownership guidelines in place and anti‑hedging policy strengthens alignment .
  • Regular Board and committee attendance (at least 75% for all directors in 2024); participation in executive sessions enhances independent oversight dynamic even within controlled structure .

Risk Indicators and RED FLAGS

  • Not independent due to family ties (brother‑in‑law to CEO and to a director; spouse is a trustee of the controlling Quad Voting Trust), creating potential conflicts—especially salient given his role as Finance Committee Chair overseeing capital structure and financing decisions .
  • Controlled company status with no lead independent director and no nominating committee; mitigations (independent Audit Committee and majority independent Board) are present but structural risk to minority shareholder influence remains .
  • Finance Committee composition includes two non‑independent directors (Harned and Dr. Flores), reducing independence on a committee with strategic financing oversight, though not required by NYSE rules; prudence suggests enhanced disclosure and processes for managing related‑party and conflict situations .

Implications for investors

  • Expect strong financial/acquisition discipline input from Harned; however, independence concerns and family control can weigh on governance quality perception. Scrutiny of related‑party oversight, capital allocation rationales, and clear recusal practices is warranted to sustain investor confidence .

Citations

  • Director bio; family ties; external boards; education .
  • Independence determination; controlled company; no lead independent director .
  • Board/committee meetings; attendance; executive sessions .
  • Director compensation program; Harned’s 2024 director pay .
  • Director grant cap .
  • Beneficial ownership table and footnotes for Harned and Quad Voting Trust .
  • Policies on hedging/pledging; stock ownership guidelines .
  • Clawback/recoupment under 2020 Plan .
  • Insider Form 4 (DSUs)

Best AI for Equity Research

Performance on expert-authored financial analysis tasks

Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%

Best AI for Equity Research

Performance on expert-authored financial analysis tasks

Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%